Your account is not claimed yet. You can sign up with ORCID to claim your account.

Laura Kohtamäki

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Patient Reported Outcomes

Multiple Sclerosis

Top Venues

Acta oncologica (Stockholm, Sweden)

Cancer immunology, immunotherapy : CII

Helsinki University Central Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helsinki University Central Hospital Apr 30o 2011

Finland

Medical Oncologist :: Oncology

Publications

Laura Kohtamäki, Suvi-Katri Leivonen, Siru Mäkelä, Susanna Juteau, Sirpa Leppa, Micaela M Hernberg
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients. Acta oncologica (Stockholm, Sweden) (2023)
Siru Mäkelä, Laura Kohtamäki, Marjut Laukka, Susanna M Juteau, Micaela M Hernberg
Limited-duration anti-PD-1 therapy for patients with metastatic melanoma. Acta oncologica (Stockholm, Sweden) 59 (4) (2020)
Henna Kasanen, Micaela M Hernberg, Siru Mäkelä, Oscar Brück, Susanna Juteau, Laura Kohtamäki, Mette Ilander, Mohamed El Missiry, Anna Kreutzman
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer immunology, immunotherapy : CII 69 (5) (2020)